PRESS RELEASE published on 01/26/2024 at 08:30, 1 year 11 months ago Ondine Unveils New Research at SPIE Photonics West Ondine Biomedical Inc. will present new research on photodisinfection and nasal decolonization at the SPIE Photonics West conference in San Francisco, California. The presentation will showcase the effectiveness of Steriwave as a nasal decolonization method. Ondine Biomedical Inc. SPIE Photonics West Photodisinfection Nasal Decolonization Steriwave
PRESS RELEASE published on 01/26/2024 at 08:00, 1 year 11 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 120,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange through Numis Securities Ltd, as part of its share buyback program. Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin Numis Securities Ltd
PRESS RELEASE published on 01/26/2024 at 08:00, 1 year 11 months ago Superdry plc: FY24 Half Year Results Superdry plc announces challenging H1 FY24 results with 23.5% revenue decline due to consumer retail market and unseasonal weather. The company focuses on cost and inventory reduction for long-term success. Superdry Plc Cost Reduction H1 FY24 Results Revenue Decline Inventory Reduction
PRESS RELEASE published on 01/26/2024 at 08:00, 1 year 11 months ago Superdry plc: Directorate Change Superdry plc announces the resignation of Shaun Wills as CFO and the appointment of Giles David as Interim CFO, with a smooth transition expected over the next two months. CFO Superdry Plc Directorate Change Shaun Wills Giles David
PRESS RELEASE published on 01/26/2024 at 08:00, 1 year 11 months ago MESH Automation to Showcase Innovative Cobot Depalletizing and Palletizing Solutions at MODEX 2024 MESH Automation to showcase advanced cobot depalletizing and palletizing solutions at MODEX 2024 Show, emphasizing commitment to automation in manufacturing and distribution. Visit booth A12327 for live demonstrations and interactive experiences. MESH Automation MODEX 2024 Cobot Depalletizing Palletizing
PRESS RELEASE published on 01/26/2024 at 07:01, 1 year 11 months ago Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza. Longstanding Chairman Albert Baehny to step down at the 2024 AGM. Key figure in Lonza's transformation to a healthcare manufacturing leader. Lonza Jean-Marc Huët Albert M. Baehny Chairman Healthcare Manufacturing
PRESS RELEASE published on 01/26/2024 at 07:00, 1 year 11 months ago SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory SCHOTT Pharma AG & Co. KGaA delivers on 2023 targets with 9% revenue growth to EUR 899m and maintains high EBITDA margin of 26.6%. Strategic shift towards high-value solutions accelerates with strong profitability. Revenue Growth EBITDA Margin SCHOTT Pharma Annual Report Forecast
PRESS RELEASE published on 01/26/2024 at 07:00, 1 year 11 months ago Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028 Sartorius expects profitable growth in 2024 with double-digit annual sales revenue growth projected through to 2028. Sales revenue declined in 2023 due to soft demand and geopolitical uncertainties. Rapid leverage reduction through strong operating cash flow planned. 2023 Results 2024 Guidance Sartorius Profitable Growth Sales Revenue
PRESS RELEASE published on 01/26/2024 at 07:00, 1 year 11 months ago Sartorius Stedim Biotech publie ses résultats préliminaires non audités pour l’exercice 2023 et fournit ses prévisions pour 2024 ainsi que de nouvelles perspectives à moyen terme Sartorius Stedim Biotech publie ses résultats préliminaires non audités pour l’exercice 2023 et fournit ses prévisions pour 2024 ainsi que de nouvelles perspectives à moyen terme Exercice 2023 Sartorius Stedim Biotech Résultats Préliminaires Prévisions 2024 Perspectives À Moyen Terme
PRESS RELEASE published on 01/26/2024 at 07:00, 1 year 11 months ago Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook. The company expects sales revenue growth in the mid to high single-digit percentage range with an underlying profit margin of more than 30 percent. Keywords: Sartorius Stedim Biotech, preliminary results, fiscal 2023, 2024 guidance, midterm outlook. Preliminary Results Sartorius Stedim Biotech Fiscal 2023 2024 Guidance Midterm Outlook
Published on 01/15/2026 at 09:01, 3 hours 13 minutes ago Formation Metals Expands Phase 1 Drill Program to 14,000 Metres at its Advanced N2 Gold Project
Published on 01/15/2026 at 05:57, 6 hours 17 minutes ago Caledonia Announces Pricing of Upsized $125 Million Offering of 5.875% Convertible Senior Notes Due 2033
Published on 01/15/2026 at 03:50, 8 hours 24 minutes ago Zimtu Capital Corp. – Early Warning News Release
Published on 01/15/2026 at 03:15, 8 hours 59 minutes ago GEC(R) Langara Receives Approval for 26-Storey Flagship Project
Published on 01/15/2026 at 02:00, 10 hours 14 minutes ago Green Bridge Announces Non-Brokered Private Placement for Gross Proceeds of up to C$4 Million
Published on 01/15/2026 at 12:08, 5 minutes ago In 2025, the Nordex Group accounted for approx. 32% of new onshore wind turbine installations (MW) in Germany
Published on 01/15/2026 at 11:50, 24 minutes ago HEIDELBERG strengthens financing structure – early extension and increase of syndicated credit facility represents a solid foundation for financing
Published on 01/15/2026 at 11:45, 29 minutes ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc
Published on 01/15/2026 at 11:25, 48 minutes ago Heliad invests in Aikido to drive the future of self-securing software
Published on 01/15/2026 at 11:20, 53 minutes ago Sopra Steria named among climate action leaders by CDP for the ninth consecutive year
Published on 01/15/2026 at 11:32, 41 minutes ago Bilan semestriel du contrat de liquidité AIR LIQUIDE
Published on 01/15/2026 at 11:32, 41 minutes ago Semi-annual update on the AIR LIQUIDE liquidity contract
Published on 01/15/2026 at 08:00, 4 hours 14 minutes ago L’IDI élargit son Comité Exécutif et renforce son équipe d’investissement
Published on 01/14/2026 at 17:45, 18 hours 29 minutes ago STEF : Bilan semestriel du contrat de liquidité au 31/12/2025